The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Retinal Disorders Therapy Market Research Report 2024
Synopsis
Retinal disorders therapy includes medical interventions and treatments used to manage various retinal disorders, such as age-related macular degeneration, diabetic retinopathy, and retinal detachment.
The global Retinal Disorders Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for retinal disorders therapy is driven by the increasing prevalence of retinal disorders, particularly in the aging population, and the demand for effective and innovative treatments to preserve vision and prevent vision loss. The market's growth is also influenced by advancements in retinal imaging and drug delivery technologies.
This report aims to provide a comprehensive presentation of the global market for Retinal Disorders Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retinal Disorders Therapy.
Report Scope
The Retinal Disorders Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Retinal Disorders Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Retinal Disorders Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ALLERGAN
AbbVie
Alimera Sciences
Janssen Biotech
Swedish Orphan Biovitrum
Roche
Bristol-Myers Squibb
Genzyme
Genentech
OCULAR THERAPEUTIX
Bausch & Lomb
UCBCares
Aier Eye Hospital
Alcon Holdings, Inc.
Eyebright Medical
Kanghong Pharmaceutical
Huaxia Eye Hospital
Xingqi Pharmaceutical
Segment by Type
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Retinal Disorders Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Retinal disorders therapy includes medical interventions and treatments used to manage various retinal disorders, such as age-related macular degeneration, diabetic retinopathy, and retinal detachment.
The global Retinal Disorders Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for retinal disorders therapy is driven by the increasing prevalence of retinal disorders, particularly in the aging population, and the demand for effective and innovative treatments to preserve vision and prevent vision loss. The market's growth is also influenced by advancements in retinal imaging and drug delivery technologies.
This report aims to provide a comprehensive presentation of the global market for Retinal Disorders Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retinal Disorders Therapy.
Report Scope
The Retinal Disorders Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Retinal Disorders Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Retinal Disorders Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ALLERGAN
AbbVie
Alimera Sciences
Janssen Biotech
Swedish Orphan Biovitrum
Roche
Bristol-Myers Squibb
Genzyme
Genentech
OCULAR THERAPEUTIX
Bausch & Lomb
UCBCares
Aier Eye Hospital
Alcon Holdings, Inc.
Eyebright Medical
Kanghong Pharmaceutical
Huaxia Eye Hospital
Xingqi Pharmaceutical
Segment by Type
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Retinal Disorders Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Disorders Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Age Related Macular Degeneration
1.2.3 Diabetic Retinopathy
1.2.4 Ocular Inflammatory Disease (Uveitis)
1.2.5 Macular Hole
1.3 Market by Application
1.3.1 Global Retinal Disorders Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Retinal Disorders Therapy Market Perspective (2019-2030)
2.2 Retinal Disorders Therapy Growth Trends by Region
2.2.1 Global Retinal Disorders Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Retinal Disorders Therapy Historic Market Size by Region (2019-2024)
2.2.3 Retinal Disorders Therapy Forecasted Market Size by Region (2025-2030)
2.3 Retinal Disorders Therapy Market Dynamics
2.3.1 Retinal Disorders Therapy Industry Trends
2.3.2 Retinal Disorders Therapy Market Drivers
2.3.3 Retinal Disorders Therapy Market Challenges
2.3.4 Retinal Disorders Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retinal Disorders Therapy Players by Revenue
3.1.1 Global Top Retinal Disorders Therapy Players by Revenue (2019-2024)
3.1.2 Global Retinal Disorders Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Retinal Disorders Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Retinal Disorders Therapy Revenue
3.4 Global Retinal Disorders Therapy Market Concentration Ratio
3.4.1 Global Retinal Disorders Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Disorders Therapy Revenue in 2023
3.5 Retinal Disorders Therapy Key Players Head office and Area Served
3.6 Key Players Retinal Disorders Therapy Product Solution and Service
3.7 Date of Enter into Retinal Disorders Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Disorders Therapy Breakdown Data by Type
4.1 Global Retinal Disorders Therapy Historic Market Size by Type (2019-2024)
4.2 Global Retinal Disorders Therapy Forecasted Market Size by Type (2025-2030)
5 Retinal Disorders Therapy Breakdown Data by Application
5.1 Global Retinal Disorders Therapy Historic Market Size by Application (2019-2024)
5.2 Global Retinal Disorders Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Retinal Disorders Therapy Market Size (2019-2030)
6.2 North America Retinal Disorders Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Retinal Disorders Therapy Market Size by Country (2019-2024)
6.4 North America Retinal Disorders Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Retinal Disorders Therapy Market Size (2019-2030)
7.2 Europe Retinal Disorders Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Retinal Disorders Therapy Market Size by Country (2019-2024)
7.4 Europe Retinal Disorders Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Retinal Disorders Therapy Market Size (2019-2030)
8.2 Asia-Pacific Retinal Disorders Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Retinal Disorders Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Retinal Disorders Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Retinal Disorders Therapy Market Size (2019-2030)
9.2 Latin America Retinal Disorders Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Retinal Disorders Therapy Market Size by Country (2019-2024)
9.4 Latin America Retinal Disorders Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retinal Disorders Therapy Market Size (2019-2030)
10.2 Middle East & Africa Retinal Disorders Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Retinal Disorders Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Retinal Disorders Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ALLERGAN
11.1.1 ALLERGAN Company Detail
11.1.2 ALLERGAN Business Overview
11.1.3 ALLERGAN Retinal Disorders Therapy Introduction
11.1.4 ALLERGAN Revenue in Retinal Disorders Therapy Business (2019-2024)
11.1.5 ALLERGAN Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Detail
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Retinal Disorders Therapy Introduction
11.2.4 AbbVie Revenue in Retinal Disorders Therapy Business (2019-2024)
11.2.5 AbbVie Recent Development
11.3 Alimera Sciences
11.3.1 Alimera Sciences Company Detail
11.3.2 Alimera Sciences Business Overview
11.3.3 Alimera Sciences Retinal Disorders Therapy Introduction
11.3.4 Alimera Sciences Revenue in Retinal Disorders Therapy Business (2019-2024)
11.3.5 Alimera Sciences Recent Development
11.4 Janssen Biotech
11.4.1 Janssen Biotech Company Detail
11.4.2 Janssen Biotech Business Overview
11.4.3 Janssen Biotech Retinal Disorders Therapy Introduction
11.4.4 Janssen Biotech Revenue in Retinal Disorders Therapy Business (2019-2024)
11.4.5 Janssen Biotech Recent Development
11.5 Swedish Orphan Biovitrum
11.5.1 Swedish Orphan Biovitrum Company Detail
11.5.2 Swedish Orphan Biovitrum Business Overview
11.5.3 Swedish Orphan Biovitrum Retinal Disorders Therapy Introduction
11.5.4 Swedish Orphan Biovitrum Revenue in Retinal Disorders Therapy Business (2019-2024)
11.5.5 Swedish Orphan Biovitrum Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Retinal Disorders Therapy Introduction
11.6.4 Roche Revenue in Retinal Disorders Therapy Business (2019-2024)
11.6.5 Roche Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Retinal Disorders Therapy Introduction
11.7.4 Bristol-Myers Squibb Revenue in Retinal Disorders Therapy Business (2019-2024)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Genzyme
11.8.1 Genzyme Company Detail
11.8.2 Genzyme Business Overview
11.8.3 Genzyme Retinal Disorders Therapy Introduction
11.8.4 Genzyme Revenue in Retinal Disorders Therapy Business (2019-2024)
11.8.5 Genzyme Recent Development
11.9 Genentech
11.9.1 Genentech Company Detail
11.9.2 Genentech Business Overview
11.9.3 Genentech Retinal Disorders Therapy Introduction
11.9.4 Genentech Revenue in Retinal Disorders Therapy Business (2019-2024)
11.9.5 Genentech Recent Development
11.10 OCULAR THERAPEUTIX
11.10.1 OCULAR THERAPEUTIX Company Detail
11.10.2 OCULAR THERAPEUTIX Business Overview
11.10.3 OCULAR THERAPEUTIX Retinal Disorders Therapy Introduction
11.10.4 OCULAR THERAPEUTIX Revenue in Retinal Disorders Therapy Business (2019-2024)
11.10.5 OCULAR THERAPEUTIX Recent Development
11.11 Bausch & Lomb
11.11.1 Bausch & Lomb Company Detail
11.11.2 Bausch & Lomb Business Overview
11.11.3 Bausch & Lomb Retinal Disorders Therapy Introduction
11.11.4 Bausch & Lomb Revenue in Retinal Disorders Therapy Business (2019-2024)
11.11.5 Bausch & Lomb Recent Development
11.12 UCBCares
11.12.1 UCBCares Company Detail
11.12.2 UCBCares Business Overview
11.12.3 UCBCares Retinal Disorders Therapy Introduction
11.12.4 UCBCares Revenue in Retinal Disorders Therapy Business (2019-2024)
11.12.5 UCBCares Recent Development
11.13 Aier Eye Hospital
11.13.1 Aier Eye Hospital Company Detail
11.13.2 Aier Eye Hospital Business Overview
11.13.3 Aier Eye Hospital Retinal Disorders Therapy Introduction
11.13.4 Aier Eye Hospital Revenue in Retinal Disorders Therapy Business (2019-2024)
11.13.5 Aier Eye Hospital Recent Development
11.14 Alcon Holdings, Inc.
11.14.1 Alcon Holdings, Inc. Company Detail
11.14.2 Alcon Holdings, Inc. Business Overview
11.14.3 Alcon Holdings, Inc. Retinal Disorders Therapy Introduction
11.14.4 Alcon Holdings, Inc. Revenue in Retinal Disorders Therapy Business (2019-2024)
11.14.5 Alcon Holdings, Inc. Recent Development
11.15 Eyebright Medical
11.15.1 Eyebright Medical Company Detail
11.15.2 Eyebright Medical Business Overview
11.15.3 Eyebright Medical Retinal Disorders Therapy Introduction
11.15.4 Eyebright Medical Revenue in Retinal Disorders Therapy Business (2019-2024)
11.15.5 Eyebright Medical Recent Development
11.16 Kanghong Pharmaceutical
11.16.1 Kanghong Pharmaceutical Company Detail
11.16.2 Kanghong Pharmaceutical Business Overview
11.16.3 Kanghong Pharmaceutical Retinal Disorders Therapy Introduction
11.16.4 Kanghong Pharmaceutical Revenue in Retinal Disorders Therapy Business (2019-2024)
11.16.5 Kanghong Pharmaceutical Recent Development
11.17 Huaxia Eye Hospital
11.17.1 Huaxia Eye Hospital Company Detail
11.17.2 Huaxia Eye Hospital Business Overview
11.17.3 Huaxia Eye Hospital Retinal Disorders Therapy Introduction
11.17.4 Huaxia Eye Hospital Revenue in Retinal Disorders Therapy Business (2019-2024)
11.17.5 Huaxia Eye Hospital Recent Development
11.18 Xingqi Pharmaceutical
11.18.1 Xingqi Pharmaceutical Company Detail
11.18.2 Xingqi Pharmaceutical Business Overview
11.18.3 Xingqi Pharmaceutical Retinal Disorders Therapy Introduction
11.18.4 Xingqi Pharmaceutical Revenue in Retinal Disorders Therapy Business (2019-2024)
11.18.5 Xingqi Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
